CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- Open-market buys, last 90 days
- $49,118
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,118. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-28 | Palumbo Joseph M Chief Medical Officer | Purchase | +4,843 | $2.16 | $10K | 6,036 |
| 2026-08-28 | Chappell Amy Suzon Director | Purchase | +727 | $2.16 | $2K | 727 |
| 2026-08-28 | KIM JOANNE WENDY Chief Financial Officer | Purchase | +2,500 | $2.18 | $5K | 3,441 |
| 2026-08-27 | DO CUONG V President & CEO | Purchase | +15,210 | $2.08 | $32K | 16,117 |
| 2026-01-05 | Palumbo Joseph M Chief Medical Officer | Grant or award · Stock Option (right to buy) | +132,000 | 132,000 | ||
| 2026-01-05 | KIM JOANNE WENDY Chief Financial Officer | Grant or award · Stock Option (right to buy) | +110,100 | 110,100 | ||
| 2026-01-05 | ROGICH SIGMUND Director | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2026-01-05 | ROGICH SIGMUND Director | Grant or award · Stock Option (right to buy) | +141,100 | 141,100 | ||
| 2026-01-05 | DO CUONG V President & CEO | Grant or award · Stock Option (right to buy) | +665,300 | 665,300 | ||
| 2026-01-05 | Sherman Michael Edward Director | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2026-01-05 | Sherman Michael Edward Director | Grant or award · Stock Option (right to buy) | +341,100 | 341,100 | ||
| 2026-01-05 | Farag Kameel D. Director | Grant or award · Stock Option (right to buy) | +57,500 | 57,500 | ||
| 2026-01-05 | Chappell Amy Suzon Director | Grant or award · Stock Option (right to buy) | +57,500 | 57,500 | ||
| 2026-01-05 | Lang James Paul Director | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2026-01-05 | Lang James Paul Director | Grant or award · Stock Option (right to buy) | +330,500 | 330,500 | ||
| 2025-08-07 | DO CUONG V President & CEO | Purchase | +5,000 | 9,992 | ||
| 2025-08-07 | DO CUONG V President & CEO | Purchase · Warrants (right to buy) | +5,000 | 5,050 | ||
| 2024-12-20 | ROGICH SIGMUND Director | Grant or award · Stock Option (right to buy) | +22,070 | 22,070 | ||
| 2024-12-20 | BERMAN RICHARD J Director | Grant or award · Stock Option (right to buy) | +23,155 | 23,155 | ||
| 2024-12-20 | Sherman Michael Edward Director | Grant or award · Stock Option (right to buy) | +23,325 | 23,325 |
Page 1 of 10 · 193 trades